Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays' production systems

International Journal of Pharmaceutics

Volumn 458, Issue 1, 2013, Pages 39-47

  Zarogoulidis, Paul ^a,b   Petridis, Dimitris ^c   Ritzoulis, Christos ^c   Li, Qiang ^d   Huang, Haidong ^d   Ning, Yunye ^d   Darwiche, Kaid ^b   Freitag, Lutz ^b   Zarogoulidis, Konstantinos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aerosol insulin; Jet nebulizers; Ultrasound

Indexed keywords

HUMAN INSULIN; INSULIN GLARGINE; NEUTRAL INSULIN;

AEROSOL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FACE MASK; JET NEBULIZER; LOADING DRUG DOSE; NEBULIZATION; NEBULIZER; PACKAGING; PARTICLE SIZE; PRIORITY JOURNAL; ULTRASOUND; ULTRASOUND NEBULIZER;

ACTRAPID (PUBCHEM SID: 135350514); AEROSOL INSULIN; CARBOPLATIN (PUBCHEM CID: 10339178); CISPLATIN (PUBCHEM CID: 84093); DOCETAXEL (PUBCHEM CID: 148124); DOXORUBICIN (PUBCHEM CID: 31703); GEMCITABINE (PUBCHEM CID: 60750); HUMULIN REGULAR (PUBMED CID: 16129672); JET-NEBULIZERS; LANTUS (PUBCHEM CID: 44146714); PACLITAXEL (PUBCHEM CID: 36314); TOBRAMYCIN (PUBCHEM CID: 36294); ULTRASOUND;

AEROSOLS; EQUIPMENT DESIGN; INSULIN; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; ULTRASONICS;

EID: 84888378135     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.10.019     Document Type: Article

References (81)

1. Operating instructions for ultrasonic atomizing nozzle systems v1.2, Sono-Tek Co., 2001.
2. Anonymous Insulin inhalation - Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin - Nektar, PEGylated insulin - Nektar Drugs RD 5 2004 166 170
3. M. Amidi, H.C. Pellikaan, A.H. de Boer, D.J. Crommelin, W.E. Hennink, and W. Jiskoot Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery Eur. J. Pharm. Biopharm. 68 2008 191 200
4. R. Angelo, K. Rousseau, M. Grant, A. Leone-Bay, and P. Richardson Technosphere insulin: defining the role of Technosphere particles at the cellular level J. Diabetes Sci. Technol. 3 2009 545 554
5. R.H. Becker, S. Sha, A.D. Frick, and R.J. Fountaine The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin Diabetes Care 29 2006 277 282 (Pubitemid 44106504)
6. R. Bi, W. Shao, Q. Wang, and N. Zhang Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery J. Biomed. Nanotechnol. 5 2009 84 92
7. C. Bosquillon Drug transporters in the lung - do they play a role in the biopharmaceutics of inhaled drugs J. Pharm. Sci. 99 2010 2240 2255
8. ®) therapy: a retrospective pooled analysis of controlled phase 2 and 3 trials Diabetologia 2006
9. J.C. Cappelleri, W.T. Cefalu, J. Rosenstock, I.A. Kourides, and R.A. Gerber Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen Clin. Ther. 24 2002 552 564 (Pubitemid 34492877)
10. ®) improves the glycemic control in patients with type 2 diabetes failing combination oral agents: a 3-month, randomized, compartive trial Diadetologia 45 2002 A260
11. J. Chancellor, S. Aballea, A. Lawrence, R. Sheldon, S. Cure, J. Plun-Favreau, and N. Marchant Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens Pharmacoeconomics 26 2008 217 234 (Pubitemid 351271380)
12. M.M. Clay, D. Pavia, S.P. Newman, and S.W. Clarke Factors influencing the size distribution of aerosols from jet nebulisers Thorax 38 1983 755 759 (Pubitemid 13019505)
13. K. Darwiche, P. Zarogoulidis, N.K. Karamanos, K. Domvri, E. Chatzaki, T.C. Constantinidis, S. Kakolyris, and K. Zarogoulidis Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology Future Oncol. 9 2013 505 525
14. J.B. Davies, and J. Bromilow Bacterial filter obstruction with the use of ultrasonic nebulisation Anaesthesia 66 2011 394 395
15. S.S. Davis, and M.D. Burb Physico-chemical studies on aerosol solutions for drug delivery. 3. The effect of relative humidity on the particle size of inhalation aerosols Int. J. Pharm. 1 1978 303 314 (Pubitemid 9050662)
16. J.H. Dennis, S.C. Stenton, J.R. Beach, A.J. Avery, E.H. Walters, and D.J. Hendrick Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output Thorax 45 1990 728 732 (Pubitemid 20351897)
17. F. Depreter, and K. Amighi Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration Eur. J. Pharm. Biopharm. 76 2010 454 463
18. F. Depreter, A. Burniat, D. Blocklet, S. Lacroix, M. Cnop, F. Fery, N.V. Aelst, G. Pilcer, M. Deleers, S. Goldman, and K. Amighi Comparative pharmacoscintigraphic and pharmacokinetic evaluation of two new formulations of inhaled insulin in type 1 diabetic patients Eur. J. Pharm. Biopharm. 80 2012 4 13
19. Z. Du, C. Tang, Y.X. Guan, S.J. Yao, and Z.Q. Zhu Bioactive insulin microparticles produced by supercritical fluid assisted atomization with an enhanced mixer Int. J. Pharm. 454 2013 174 182
20. L. Fabbri Pulmonary safety of inhaled insulins: a review of the current data Curr. Med. Res. Opin. 22 2006 21 28
21. W. Fan, K. Nakazawa, S. Abe, M. Inoue, M. Kitagawa, N. Nagahara, and K. Makita Inhaled aerosolized insulin ameliorates hyperglycemia-induced inflammatory responses in the lungs in an experimental model of acute lung injury Crit. Care 17 2013 R83
22. G.A. Ferron, K.F. Kerrebijn, and J. Weber Properties of aerosols produced with three nebulizers Am. Rev. Respir. Dis. 114 1976 899 908
23. W.H. Finlay The Mechanisms of Inhaled Pharmaceutical Aerosols 2001 Academic Press London 175 220
24. W.H. Finlay The Mechanisms of Inhaled Pharmaceutical Aerosols 2001 Academic Press London 47 91
25. G.N. Foust, W.A. Potter, M.D. Wilons, and E.B. Golden Shortcomings of using two jet nebulizers in tandem with an aerosol face mask for optimal oxygen therapy Chest 99 1991 1346 1351
26. S. Garg, J. Rosenstock, B.L. Silverman, B. Sun, C.S. Konkoy, A. de la Pena, and D.B. Muchmore Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes Diabetologia 49 2006 891 899
27. N. Genina, H. Raikkonen, J. Heinamaki, O. Antikainen, S. Siiria, P. Veski, and J. Yliruusi Effective modification of particle surface properties using ultrasonic water mist AAPS PharmSciTech 10 2009 282 288
28. H. Hamishehkar, J. Emami, A.R. Najafabadi, K. Gilani, M. Minaiyan, H. Mahdavi, and A. Nokhodchi Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin Int. J. Pharm. 389 2010 74 85
29. T. Heise, A. Brugger, C. Cook, U. Eckers, A. Hutchcraft, L. Nosek, K. Rave, J. Troeger, P. Valaitis, S. White, and L. Heinemann PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler Diabetes Obes. Metab. 11 2009 455 459
30. T. Heise, L. Nosek, H. Spitzer, L. Heinemann, E. Niemoller, A.D. Frick, and R.H. Becker Insulin glulisine: a faster onset of action compared with insulin lispro Diabetes Obes. Metab. 9 2007 746 753 (Pubitemid 47261856)
31. R.I. Henkin Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action Nutrition 26 2010 33 39
32. R.I. Henkin Intranasal insulin: from nose to brain Nutrition 26 2010 624 633
33. R.R. Henry, S.R. Mudaliar, W.C. Howland 3rd, N. Chu, D. Kim, B. An, and R.R. Reinhardt Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects Diabetes Care 26 2003 764 769 (Pubitemid 36929341)
34. A.J. Hickey Pharmaceutical Inhalation Aerosol Technology 1992 Marcer Decker New York 155 185
35. A. Himmelmann, J. Jendle, A. Mellen, A.H. Petersen, U.L. Dahl, and P. Wollmer The impact of smoking on inhaled insulin Diabetes Care 26 2003 677 682 (Pubitemid 36929327)
36. B. Hrvacic, B. Bosnjak, M. Tudja, M. Mesic, and M. Mercep Applicability of an ultrasonic nebulization system for the airways delivery of beclomethasone dipropionate in a murine model of asthma Pharm. Res. 23 2006 1765 1775 (Pubitemid 44200540)
37. A.H. Kendrick, E.C. Smith, and R.S. Wilson Selecting and using nebuliser equipment Thorax 52 1997 S92 S101
38. S. Kitamura Effects of cigarette smoking on metabolic events in the lung Environ. Health Perspect. 72 1987 283 296 (Pubitemid 18058076)
39. E. Kleemann, L.A. Dailey, H.G. Abdelhady, T. Gessler, T. Schmehl, C.J. Roberts, M.C. Davies, W. Seeger, and T. Kissel Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization J. Control. Release 100 2004 437 450 (Pubitemid 39572923)
40. C. Klingler, B.W. Muller, and H. Steckel Insulin-micro- and nanoparticles for pulmonary delivery Int. J. Pharm. 377 2009 173 179
41. P. Labs NDA 21-868/EXUBERA: U.S. package insert, 2006. 2006 Pfizer Labs New York
42. C.B. Landersdorfer, and W.J. Jusko Pharmacokinetic/pharmacodynamic modeling of glucose clamp effects of inhaled and subcutaneous insulin in healthy volunteers and diabetic patients Drug. Metab. Pharmacokinet. 25 2010 418 429
43. C.A. Lasagna-Reeves, A.L. Clos, T. Midoro-Hiriuti, R.M. Goldblum, G.R. Jackson, and R. Kayed Inhaled insulin forms toxic pulmonary amyloid aggregates Endocrinology 151 2010 4717 4724
44. H.L. Lin, R.D. Restrepo, D.S. Gardenhire, and J.L. Rau Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model Respir. Care 52 2007 1021 1026
45. M.C. Liu, R.J. Riese, K. Van Gundy, P. Norwood, B.E. Sullivan, P.F. Schwartz, and J.G. Teeter Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes Eur. Respir. J. 32 2008 180 188
46. R.V. Lourenco, and E. Cotromanes Clinical aerosols. I. Characterisation of aerosols and their diagnostic uses Arch. Intern. Med. 142 1992 2163 2172
47. X. Lu, S. Yang, and J.R. Evans Microfeeding with different ultrasonic nozzle designs Ultrasonics 49 2009 514 521
48. P. Mayer, U. Reitzenstein, M. Warnken, H. Enzmann, and K. Racke Insulin action on H292 bronchial carcinoma cells as compared to normal bronchial epithelial cells Pulm. Pharmacol. Ther. 25 2012 104 114
49. A. McElduff, L.E. Mather, P.C. Kam, and P. Clauson Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System Br. J. Clin. Pharmacol. 59 2005 546 551 (Pubitemid 40632245)
50. T.T. Mercer, R.F. Goddard, and R.L. Flores Effect of auxiliary air flow on the output characteristics of compressed-air nebulizers Ann. Allergy 27 1969 211 217
51. M. Nemoto, Y. Hiki, K. Shimada, N. Nakai, K. Fujimoto, S. Inoue, N. Sakurada, H. Kaneko, M. Sugita, M. Okabe, and T. Sasaki Novel hormonal delivery method using the ink-jet technology: application to pulmonary insulin therapies Diabetes Technol. Ther. 13 2011 509 517
52. S.P. Newman, P.G. Pellow, M.M. Clay, and S.W. Clarke Evaluation of jet nebulisers for use with gentamicin solution Thorax 40 1985 671 676 (Pubitemid 15229602)
53. R.W. Niven, A.Y. Ip, S. Mittelman, S.J. Prestrelski, and T. Arakawa Some factors associated with the ultrasonic nebulization of proteins Pharm. Res. 12 1995 53 59
54. C. O'Callaghan, and P.W. Barry The science of nebulised drug delivery Thorax 52 1997 S31 S44
55. J.S. Patton, J.G. Bukar, and M.A. Eldon Clinical pharmacokinetics and pharmacodynamics of inhaled insulin Clin. Pharmacokinet. 43 2004 781 801 (Pubitemid 39382220)
56. A.H. Petersen, S. Korsatko, G. Kohler, A. Wutte, H. Olschewski, T. Sparre, J. Rastam, P. Wollmer, and T.R. Pieber The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma Br. J. Clin. Pharmacol. 69 2010 271 278
57. A. Pfutzner, and T. Forst Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism Expert Opin. Drug Deliv. 2 2005 1097 1106 (Pubitemid 41701207)
58. E. Potocka, R.A. Baughman, and H. Derendorf Population pharmacokinetic model of human insulin following different routes of administration J. Clin. Pharmacol. 51 2011 1015 1024
59. T. Quattrin, A. Belanger, N.J. Bohannon, and S.L. Schwartz Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial Diabetes Care 27 2004 2622 2627 (Pubitemid 39441461)
60. K. Rave, A. de la Pena, F.S. Tibaldi, L. Zhang, B. Silverman, M. Hausmann, L. Heinemann, and D.B. Muchmore AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability Diabetes Care 30 2007 1777 1782 (Pubitemid 47036351)
61. K. Rave, L. Nosek, L. Heinemann, A. Frick, R. Becker, and C. Kapitza Dependency of the metabolic effect of sc-injected human regular insulin on intra-abdominal fat in patients with type 2 diabetes Horm. Metab. Res. 36 2004 307 311 (Pubitemid 38703792)
62. T. Richardson, and D. Kerr Skin-related complications of insulin therapy: epidemiology and emerging management strategies Am. J. Clin. Dermatol. 4 2003 661 667 (Pubitemid 37411982)
63. J. Rosenstock, B. Zinman, L.J. Murphy, S.C. Clement, P. Moore, C.K. Bowering, R. Hendler, S.P. Lan, and W.T. Cefalu Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial Ann. Intern. Med. 143 2005 549 558
64. R.R. Rubin, and M. Peyrot Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ) Health Qual. Life Outcomes 8 2010 32
65. H. Shapiro, I. Kagan, M. Shalita-Chesner, J. Singer, and P. Singer Inhaled aerosolized insulin: a topical anti-inflammatory treatment for acute lung injury and respiratory distress syndrome? Inflammation 33 2010 315 319
66. H. Shinohara Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesothelium in the golden hamster Anat. Rec. 249 1997 16 23 (Pubitemid 27391415)
67. J.S. Skyler, W.T. Cefalu, I.A. Kourides, W.H. Landschulz, C.C. Balagtas, S.L. Cheng, and R.A. Gelfand Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study Lancet 357 2001 331 335 (Pubitemid 32128537)
68. C.C. Smutney, E.M. Friedman, J.M. Polidoro, and N. Amin Inspiratory efforts achieved in use of the Technosphere insulin inhalation system J. Diabetes Sci. Technol. 3 2009 1175 1182
69. H. Steckel, and F. Eskandar Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers Eur. J. Pharm. Sci. 19 2003 443 455 (Pubitemid 36952406)
70. S. Steiner, A. Pfutzner, B.R. Wilson, O. Harzer, L. Heinemann, and K. Rave Technosphere/insulin - proof of concept study with a new insulin formulation for pulmonary delivery Exp. Clin. Endocrinol. Diabetes 110 2002 17 21 (Pubitemid 34136277)
71. P.J. Sterk, A. Plomp, J.F. van de Vate, and P.H. Quanjer Physical properties of aerosols produced by several jet- and ultrasonic nebulizers Bull. Eur. Physiopathol. Respir. 20 1984 65 72 (Pubitemid 14168418)
72. D.L. Swift Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols Am. Rev. Respir. Dis. 122 1980 71 77 (Pubitemid 11172649)
73. M. Tonnellier, F. Ferrari, I. Goldstein, A. Sartorius, C.H. Marquette, and J.J. Rouby Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen Anesthesiology 102 2005 995 1000 (Pubitemid 40586541)
74. F. Ungaro, R. d'Emmanuele di Villa Bianca, C. Giovino, A. Miro, R. Sorrentino, F. Quaglia, and M.I. La Rotonda Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs J. Control. Release 135 2009 25 34
75. X. Xu, C. Liu, Z. Xu, K. Tzan, M. Zhong, A. Wang, M. Lippmann, L.C. Chen, S. Rajagopalan, and Q. Sun Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue Toxicol. Sci. 124 2011 88 98
76. S. Yaturu Insulin therapies: current and future trends at dawn World J. Diabetes 4 2013 1 7
77. P. Zarogoulidis, E. Chatzaki, K. Porpodis, K. Domvri, W. Hohenforst-Schmidt, E.P. Goldberg, N. Karamanos, and K. Zarogoulidis Inhaled chemotherapy in lung cancer: future concept of nanomedicine In. J. Nanomedicine 7 2012 1551 1572
78. P. Zarogoulidis, E. Eleftheriadou, I. Sapardanis, V. Zarogoulidou, H. Lithoxopoulou, T. Kontakiotis, N. Karamanos, G. Zachariadis, M. Mabroudi, A. Zisimopoulos, and K. Zarogoulidis Feasibility and effectiveness of inhaled carboplatin in NSCLC patients Invest. New Drugs 30 2012 1628 1640
79. P. Zarogoulidis, I. Kioumis, C. Ritzoulis, D. Petridis, K. Darwiche, K. Porpodis, D. Spyratos, S. Parrish, R. Browning, Q. Li, J.F. Turner, L. Freitag, and K. Zarogoulidis New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam Int. J. Pharm. 2013
80. P. Zarogoulidis, N. Papanas, G. Kouliatsis, D. Spyratos, K. Zarogoulidis, and E. Maltezos Inhaled insulin: too soon to be forgotten J. Aerosol. Med. Pulm. Drug Deliv. 24 2011 213 223
81. P. Zarogoulidis, D. Petridis, C. Ritzoulis, K. Darwiche, D. Spyratos, H. Huang, E.P. Goldberg, L. Yarmus, Q. Li, L. Freitag, and K. Zarogoulidis Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup Int. J. Pharm. 453 2013 480 487